MedPath

Cryolipolysis for Jawline Contouring

Not Applicable
Active, not recruiting
Conditions
Body Fat Disorder
Interventions
Device: The ZELTIQ System
Registration Number
NCT03352141
Lead Sponsor
Zeltiq Aesthetics
Brief Summary

The purpose of this study is to evaluate the safety and efficacy of non-invasive reduction of subcutaneous fat along the jawline with Cryolipolysis.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
45
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Fat ReductionThe ZELTIQ SystemThe treatments are designed to see if the fat can be reduced along the jawline with Cryolipolysis.
Primary Outcome Measures
NameTimeMethod
Safety endpoint in relation to adverse eventsThrough study completion, an average of 9-months.

Measurement of device- or procedure-related adverse events. It is expected there will be zero UADEs

Photo review12 weeks post second treatment.

Correct identification of pre-treatment vs. final post-treatment visit images by two out of three blinded independent reviewers.

Secondary Outcome Measures
NameTimeMethod
Effectiveness endpoint gauged by reduction in fat layer thickness12 weeks post second treatment.

Reduction in fat layer thickness as measured by ultrasound at the final post-treatment visit.

Trial Locations

Locations (1)

Pacific Derm

🇨🇦

Vancouver, British Columbia, Canada

© Copyright 2025. All Rights Reserved by MedPath